Jotham W. Coe

4.2k total citations
44 papers, 1.9k citations indexed

About

Jotham W. Coe is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jotham W. Coe has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Organic Chemistry, 27 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jotham W. Coe's work include Nicotinic Acetylcholine Receptors Study (13 papers), Chemical synthesis and alkaloids (9 papers) and Coordination Chemistry and Organometallics (8 papers). Jotham W. Coe is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (13 papers), Chemical synthesis and alkaloids (9 papers) and Coordination Chemistry and Organometallics (8 papers). Jotham W. Coe collaborates with scholars based in United States, Canada and United Kingdom. Jotham W. Coe's co-authors include Alpay Dermenci, Guangbin Dong, Michael G. Vetelino, Hans Rollema, Michael Wirtz, Raymond S Hurst, William Roush, Stephen M. Stahl, Kathryn Williams and Leslie K. Chambers and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Jotham W. Coe

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jotham W. Coe United States 25 1.1k 825 270 256 178 44 1.9k
Arthur Gomtsyan United States 25 975 0.9× 548 0.7× 223 0.8× 555 2.2× 139 0.8× 36 2.1k
Duncan B. Judd United Kingdom 22 915 0.9× 945 1.1× 215 0.8× 204 0.8× 152 0.9× 34 2.0k
James C. Barrow United States 29 823 0.8× 1.2k 1.4× 429 1.6× 222 0.9× 71 0.4× 68 2.4k
Romano Di Fabio Italy 24 900 0.9× 609 0.7× 336 1.2× 86 0.3× 84 0.5× 104 1.7k
Christopher D. Cox United States 31 1.2k 1.1× 912 1.1× 96 0.4× 115 0.4× 233 1.3× 66 2.6k
Paul C. Trippier United States 21 827 0.8× 802 1.0× 123 0.5× 181 0.7× 79 0.4× 55 1.8k
Helmut Buschmann Germany 30 1.6k 1.5× 1.1k 1.3× 586 2.2× 391 1.5× 327 1.8× 81 3.0k
John E. Macor United States 29 1.5k 1.4× 1.3k 1.6× 691 2.6× 327 1.3× 136 0.8× 161 3.2k
Angus M. MacLeod United Kingdom 27 893 0.8× 1.1k 1.3× 912 3.4× 160 0.6× 92 0.5× 62 2.4k
D. I. C. SCOPES United Kingdom 23 772 0.7× 995 1.2× 451 1.7× 319 1.2× 60 0.3× 87 1.9k

Countries citing papers authored by Jotham W. Coe

Since Specialization
Citations

This map shows the geographic impact of Jotham W. Coe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jotham W. Coe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jotham W. Coe more than expected).

Fields of papers citing papers by Jotham W. Coe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jotham W. Coe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jotham W. Coe. The network helps show where Jotham W. Coe may publish in the future.

Co-authorship network of co-authors of Jotham W. Coe

This figure shows the co-authorship network connecting the top 25 collaborators of Jotham W. Coe. A scholar is included among the top collaborators of Jotham W. Coe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jotham W. Coe. Jotham W. Coe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernier, Louise, Jotham W. Coe, William Farrell, et al.. (2019). High‐Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary Cyclobutylboronates. Angewandte Chemie. 131(51). 18576–18580. 19 indexed citations
2.
Jones, Peter, Richard Storer, Yogesh Sabnis, et al.. (2016). Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. Journal of Medicinal Chemistry. 60(2). 767–786. 44 indexed citations
3.
Chekler, Eugene L. Piatnitski, Thomas A. Lanz, R. Aldrin Denny, et al.. (2015). Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities. Chemistry & Biology. 22(12). 1588–1596. 41 indexed citations
4.
Sperry, Jeffrey B., David B. Damon, Roberta L. Dorow, et al.. (2014). Kiloscale Buchwald–Hartwig Amination: Optimized Coupling of Base-Sensitive 6-Bromoisoquinoline-1-carbonitrile with (S)-3-Amino-2-methylpropan-1-ol. Organic Process Research & Development. 18(12). 1752–1758. 40 indexed citations
5.
Pryde, David C., Lyn H. Jones, David Gervais, et al.. (2013). Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice. PLoS ONE. 8(10). e76557–e76557. 66 indexed citations
6.
Magnus, Philip, et al.. (2013). Access to 7β-analogs of codeine with mixed μ/δ agonist activity via 6,7-α-epoxide opening. Bioorganic & Medicinal Chemistry Letters. 23(17). 4870–4874. 6 indexed citations
7.
Sakya, Subas M., Andrew C. Flick, Jotham W. Coe, et al.. (2011). Synthesis of 4-azepanones and heteroaromatic-fused azepines. Tetrahedron Letters. 53(7). 723–725. 9 indexed citations
8.
Mineur, Yann S., Emily B. Einstein, Patricia A. Seymour, et al.. (2011). α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behavioural Pharmacology. 22(4). 291–299. 42 indexed citations
9.
Chatterjee, Susmita, Pia Steensland, Jeffrey A. Simms, et al.. (2010). Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats. Neuropsychopharmacology. 36(3). 603–615. 90 indexed citations
10.
Rollema, Hans, Victor Guanowsky, Yann S. Mineur, et al.. (2009). Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect. European Journal of Pharmacology. 605(1-3). 114–116. 76 indexed citations
11.
Stevenson, Heather L., et al.. (2008). Pyridine analogs of (−)-cytisine and varenicline: cholinergic receptor probes. Tetrahedron Letters. 49(21). 3368–3371. 16 indexed citations
12.
Ende, David J. am, David C. Whritenour, & Jotham W. Coe. (2007). Cyclopentadiene: The Impact of Storage Conditions on Thermal Stability. Organic Process Research & Development. 11(6). 1141–1146. 16 indexed citations
13.
Rollema, Hans, Jotham W. Coe, Leslie K. Chambers, et al.. (2007). Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation. Trends in Pharmacological Sciences. 28(7). 316–325. 185 indexed citations
14.
Vetelino, Michael G., Michael Wirtz, Paige R. Brooks, et al.. (2006). Enantioselective Synthesis of Nicotinic Receptor Probe 7,8-Difluoro-1,2,3,4,5,6- hexahydro-1,5-methano-3-benzazocine. Organic Letters. 8(26). 5947–5950. 21 indexed citations
15.
Coe, Jotham W., Michael G. Vetelino, Michael Wirtz, et al.. (2005). In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine. Bioorganic & Medicinal Chemistry Letters. 15(12). 2974–2979. 49 indexed citations
16.
Obach, R. Scott, et al.. (2005). METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO. Drug Metabolism and Disposition. 34(1). 121–130. 166 indexed citations
17.
Coe, Jotham W., Paige R. Brooks, Michael Wirtz, et al.. (2005). 3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation. Bioorganic & Medicinal Chemistry Letters. 15(22). 4889–4897. 57 indexed citations
18.
Coe, Jotham W., Robert A. Singer, Stéphane Caron, et al.. (2004). Synthesis of 2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine via Oxidative Cleavage and Reductive Amination Strategies. Synthesis. 2004(11). 1755–1758. 7 indexed citations
19.
Brooks, Paige R., Michael Wirtz, Michael G. Vetelino, et al.. (2000). ChemInform Abstract: Boron Trichloride/Tetra‐n‐butylammonium Iodide: A Mild, Selective Combination Reagent for the Cleavage of Primary Alkyl Aryl Ethers.. ChemInform. 31(15). 2 indexed citations
20.
Coe, Jotham W., Michael G. Vetelino, & Daniel S. Kemp. (1994). Indenes via fulvene intermediates. Tetrahedron Letters. 35(36). 6627–6630. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Gomtsyan Breakdown of academic impact, for papers by Duncan B. Judd Breakdown of academic impact, for papers by James C. Barrow Breakdown of academic impact, for papers by Romano Di Fabio Breakdown of academic impact, for papers by Christopher D. Cox Breakdown of academic impact, for papers by Paul C. Trippier Breakdown of academic impact, for papers by Helmut Buschmann Breakdown of academic impact, for papers by John E. Macor Breakdown of academic impact, for papers by Angus M. MacLeod Breakdown of academic impact, for papers by D. I. C. SCOPES
Rankless by CCL
2026